RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy5111
         (132 letters)



>gnl|CDD|189008 cd09601, M1_APN_2, Peptidase M1 Aminopeptidase N family incudes
           tricorn interacting factor F3, Endoplasmic reticulum
           aminopeptidase 1 (ERAP1), Aminopeptidase Q (APQ).  This
           M1 peptidase family includes eukaryotic and bacterial
           members: aminopeptidase N (APN), aminopeptidase Q (APQ,
           laeverin), endoplasmic reticulum aminopeptidase 1
           (ERAP1) as well as tricorn interacting factor F3.
           Aminopeptidase N (APN; CD13; Alanyl aminopeptidase; EC
           3.4.11.2), a Type II integral membrane protease,
           consists of a small N-terminal cytoplasmic domain, a
           single transmembrane domain and a large extracellular
           ectodomain that contains the active site. It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and is present in a variety
           of human tissues and cell types (leukocyte, fibroblast,
           endothelial and epithelial cells). APN expression is
           dysregulated in inflammatory diseases such as chronic
           pain, rheumatoid arthritis, multiple sclerosis, systemic
           sclerosis, systemic lupus erythematosus,
           polymyositis/dermatomyosytis and pulmonary sarcoidosis,
           and is enhanced in tumor cells such as melanoma, renal,
           prostate, pancreas, colon, gastric and thyroid cancers.
           It is considered a marker of differentiation since it is
           predominantly expressed on stem cells and on cells of
           the granulocytic and monocytic lineages at distinct
           stages of differentiation. Thus, APN inhibition may lead
           to the development of anti-cancer and anti-inflammatory
           drugs. ERAP1 also known as endoplasmic reticulum
           aminopeptidase associated with antigen processing
           (ERAAP), adipocyte derived leucine aminopeptidase
           (A-LAP) or aminopeptidase regulating tumor necrosis
           factor receptor I (THFRI) shedding (ARTS-1), associates
           with the closely related ER aminopeptidase ERAP2, for
           the final trimming of peptides within the ER for
           presentation by MHC class I molecules. ERAP1 is
           associated with ankylosing spondylitis (AS), an
           inflammatory arthritis that predominantly affects the
           spine. ERAP1 also aids in the shedding of membrane-bound
           cytokine receptors. The tricorn interacting factor F3,
           together with factors F1 and F2, degrades the tricorn
           protease products, producing free amino acids, thus
           completing the proteasomal degradation pathway. F3 is
           homologous to F2, but not F1, and shows a strong
           preference for glutamate in the P1' position. APQ, also
           known as laeverin, is specifically expressed in human
           embryo-derived extravillous trophoblasts (EVTs) that
           invade the uterus during early placentation. It cleaves
           the N-terminal amino acid of various peptides such as
           angiotensin III, endokinin C, and kisspeptin-10, all
           expressed in the placenta in large quantities. APN is a
           receptor for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs are also putative Cry toxin
           receptors. Cry1 proteins are pore-forming toxins that
           bind to the midgut epithelial cell membrane of
           susceptible insect larvae, causing extensive damage.
           Several different toxins, including Cry1Aa, Cry1Ab,
           Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to
           bind to APNs; however, a direct role of APN in
           cytotoxicity has been yet to be firmly established.
          Length = 446

 Score = 87.6 bits (218), Expect = 3e-21
 Identities = 28/60 (46%), Positives = 34/60 (56%)

Query: 72  REKFLLTSKHQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFGT 131
           RE  LL      + ++ QR  +VV HE  HQWFG+LVT   W+  WLNE FA   EY G 
Sbjct: 267 RETALLYDPKTSSASNKQRVATVVAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLGV 326



 Score = 85.7 bits (213), Expect = 1e-20
 Identities = 28/63 (44%), Positives = 34/63 (53%)

Query: 1   EKFLLTSKGQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFGTR 60
           E  LL      + ++ QR  +VV HE  HQWFG+LVT   W+  WLNE FA   EY G  
Sbjct: 268 ETALLYDPKTSSASNKQRVATVVAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLGVD 327

Query: 61  MLY 63
            L 
Sbjct: 328 HLE 330


>gnl|CDD|216501 pfam01433, Peptidase_M1, Peptidase family M1.  Members of this
           family are aminopeptidases. The members differ widely in
           specificity, hydrolysing acidic, basic or neutral
           N-terminal residues. This family includes leukotriene-A4
           hydrolase, this enzyme also has an aminopeptidase
           activity.
          Length = 390

 Score = 81.2 bits (201), Expect = 4e-19
 Identities = 29/60 (48%), Positives = 34/60 (56%)

Query: 72  REKFLLTSKHQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFGT 131
           RE  LL      T++D QR   V+ HE  HQWFG+LVT   W+  WLNE FA   EY  T
Sbjct: 276 REPALLYDPGNSTSSDKQRVAEVIAHELAHQWFGNLVTMDWWDDLWLNEGFATYMEYLIT 335



 Score = 78.9 bits (195), Expect = 2e-18
 Identities = 30/63 (47%), Positives = 35/63 (55%)

Query: 1   EKFLLTSKGQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFGTR 60
           E  LL   G  T++D QR   V+ HE  HQWFG+LVT   W+  WLNE FA   EY  T 
Sbjct: 277 EPALLYDPGNSTSSDKQRVAEVIAHELAHQWFGNLVTMDWWDDLWLNEGFATYMEYLITD 336

Query: 61  MLY 63
            L 
Sbjct: 337 ALE 339


>gnl|CDD|223385 COG0308, PepN, Aminopeptidase N [Amino acid transport and
           metabolism].
          Length = 859

 Score = 70.2 bits (172), Expect = 4e-15
 Identities = 34/109 (31%), Positives = 46/109 (42%), Gaps = 20/109 (18%)

Query: 35  LVTPASWNFA-WLNEAFARLF----EYFG-----TRMLY-VQEIP---------TPIREK 74
            V P   + A +  +   R      EYFG        +  V +              REK
Sbjct: 231 YVPPGVLDRAKYALDETKRSIEFYEEYFGLPYALPIDIVAVPDFSAGAMENWGLVTFREK 290

Query: 75  FLLTSKHQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFA 123
           +LL      T +D++    V+ HE  HQWFG+LVT   W+  WLNE FA
Sbjct: 291 YLLADPETATDSDYENVEEVIAHELAHQWFGNLVTMKWWDDLWLNEGFA 339



 Score = 66.0 bits (161), Expect = 1e-13
 Identities = 24/51 (47%), Positives = 31/51 (60%)

Query: 1   EKFLLTSKGQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFA 51
           EK+LL      T +D++    V+ HE  HQWFG+LVT   W+  WLNE FA
Sbjct: 289 EKYLLADPETATDSDYENVEEVIAHELAHQWFGNLVTMKWWDDLWLNEGFA 339


>gnl|CDD|189009 cd09602, M1_APN_3, Peptidase M1 family containing Aminopeptidase N.
            This family contains bacterial and eukaryotic
           aminopeptidase N (APN; CD13; Alanyl aminopeptidase; EC
           3.4.11.2), a Type II integral membrane protease
           belonging to the M1 gluzincin family. APN consists of a
           small N-terminal cytoplasmic domain, a single
           transmembrane domain and a large extracellular
           ectodomain that contains the active site.  It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and, in higher eukaryotes,
           is present in a variety of human tissues and cell types
           (leukocyte, fibroblast, endothelial and epithelial
           cells). APN expression is dysregulated in inflammatory
           diseases such as chronic pain, rheumatoid arthritis,
           multiple sclerosis, systemic sclerosis, systemic lupus
           erythematosus, polymyositis/dermatomyosytis and
           pulmonary sarcoidosis, and is enhanced in tumor cells
           such as melanoma, renal, prostate, pancreas, colon,
           gastric and thyroid cancers. It is predominantly
           expressed on stem cells and on cells of the granulocytic
           and monocytic lineages at distinct stages of
           differentiation, thus considered a marker of
           differentiation. Thus, APN inhibition may lead to the
           development of anti-cancer and anti-inflammatory drugs.
           APNs are also present in many pathogenic bacteria and
           represent potential drug targets, Some APNs have been
           used commercially, such as one from Lactococcus lactis
           used in the food industry. APN also serves as a receptor
           for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs have also been extensively studied
           as putative Cry toxin receptors. Cry1 proteins are
           pore-forming toxins that bind to the midgut epithelial
           cell membrane of susceptible insect larvae, causing
           extensive damage. Several different toxins, including
           Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have
           been shown to bind to APNs; however, a direct role of
           APN in cytotoxicity has been yet to be firmly
           established.
          Length = 438

 Score = 60.7 bits (148), Expect = 7e-12
 Identities = 26/63 (41%), Positives = 33/63 (52%), Gaps = 5/63 (7%)

Query: 1   EKFLLTSKGQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFGTR 60
           E ++   +   TTA   R  + + HE  H WFGDLVT   WN  WLNE+FA   EY   +
Sbjct: 266 ENYVFREEV--TTAQRLRRANTIAHEMAHMWFGDLVTMKWWNDLWLNESFA---EYMAYK 320

Query: 61  MLY 63
            L 
Sbjct: 321 ALS 323



 Score = 59.9 bits (146), Expect = 1e-11
 Identities = 26/62 (41%), Positives = 33/62 (53%), Gaps = 5/62 (8%)

Query: 71  IREKFLLTSKHQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFG 130
            RE ++     + TTA   R  + + HE  H WFGDLVT   WN  WLNE+FA   EY  
Sbjct: 264 FRENYVFRE--EVTTAQRLRRANTIAHEMAHMWFGDLVTMKWWNDLWLNESFA---EYMA 318

Query: 131 TR 132
            +
Sbjct: 319 YK 320


>gnl|CDD|233857 TIGR02412, pepN_strep_liv, aminopeptidase N, Streptomyces lividans
           type.  This family is a subset of the members of the
           zinc metallopeptidase family M1 (pfam01433), with a
           single member characterized in Streptomyces lividans 66
           and designated aminopeptidase N. The spectrum of
           activity may differ somewhat from the aminopeptidase N
           clade of E. coli and most other Proteobacteria, well
           separated phylogenetically within the M1 family. The M1
           family also includes leukotriene A-4
           hydrolase/aminopeptidase (with a bifunctional active
           site).
          Length = 831

 Score = 60.2 bits (146), Expect = 1e-11
 Identities = 25/52 (48%), Positives = 31/52 (59%), Gaps = 3/52 (5%)

Query: 8   KGQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFGT 59
           + + T A+ +    V+ HE  H WFGDLVT   WN  WLNE+FA   EY GT
Sbjct: 276 RAEATRAEKENRAGVILHEMAHMWFGDLVTMRWWNDLWLNESFA---EYMGT 324



 Score = 60.2 bits (146), Expect = 1e-11
 Identities = 28/61 (45%), Positives = 34/61 (55%), Gaps = 5/61 (8%)

Query: 71  IREKFLLTSKHQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFG 130
             E FL  ++   T A+ +    V+ HE  H WFGDLVT   WN  WLNE+FA   EY G
Sbjct: 269 FAENFLHRAE--ATRAEKENRAGVILHEMAHMWFGDLVTMRWWNDLWLNESFA---EYMG 323

Query: 131 T 131
           T
Sbjct: 324 T 324


>gnl|CDD|189010 cd09603, M1_APN_4, Peptidase M1 family Aminopeptidase N.  This
           family contains mostly bacterial and some archaeal
           aminopeptidase N (APN; CD13; Alanyl aminopeptidase; EC
           3.4.11.2), a Type II integral membrane protease
           belonging to the M1 gluzincin family. APN consists of a
           small N-terminal cytoplasmic domain, a single
           transmembrane domain and a large extracellular
           ectodomain that contains the active site. It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and, in higher eukaryotes,
           is present in a variety of human tissues and cell types
           (leukocyte, fibroblast, endothelial and epithelial
           cells). APN expression is dysregulated in inflammatory
           diseases such as chronic pain, rheumatoid arthritis,
           multiple sclerosis, systemic sclerosis, systemic lupus
           erythematosus, polymyositis/dermatomyosytis and
           pulmonary sarcoidosis, and is enhanced in tumor cells
           such as melanoma, renal, prostate, pancreas, colon,
           gastric and thyroid cancers. It is predominantly
           expressed on stem cells and on cells of the granulocytic
           and monocytic lineages at distinct stages of
           differentiation, thus considered a marker of
           differentiation. Thus, APN inhibition may lead to the
           development of anti-cancer and anti-inflammatory drugs.
           APNs are also present in many pathogenic bacteria and
           represent potential drug targets, Some APNs have been
           used commercially, such as one from Lactococcus lactis
           used in the food industry. APN also serves as a receptor
           for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs have also been extensively studied
           as putative Cry toxin receptors. Cry1 proteins are
           pore-forming toxins that bind to the midgut epithelial
           cell membrane of susceptible insect larvae, causing
           extensive damage. Several different toxins, including
           Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have
           been shown to bind to APNs; however, a direct role of
           APN in cytotoxicity has been yet to be firmly
           established.
          Length = 415

 Score = 59.9 bits (146), Expect = 1e-11
 Identities = 18/34 (52%), Positives = 22/34 (64%)

Query: 18  RATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFA 51
            +  ++ HE  HQWFGD VT A W+  WLNE FA
Sbjct: 264 SSERLIAHELAHQWFGDSVTCADWSDIWLNEGFA 297



 Score = 59.9 bits (146), Expect = 1e-11
 Identities = 18/34 (52%), Positives = 22/34 (64%)

Query: 90  RATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFA 123
            +  ++ HE  HQWFGD VT A W+  WLNE FA
Sbjct: 264 SSERLIAHELAHQWFGDSVTCADWSDIWLNEGFA 297


>gnl|CDD|189002 cd09595, M1, Peptidase M1 family contains aminopeptidase N and
           leukotriene A4 hydrolase.  M1 Peptidase family includes
           aminopeptidase N (APN) and leukotriene A4 hydrolase
           (LTA4H).  All peptidases in this family bind a single
           catalytic zinc ion which is tetrahedrally co-ordinated
           by three amino acid ligands and a water molecule that
           forms the nucleophile on activation during catalysis.
           APN consists of a small N-terminal cytoplasmic domain, a
           single transmembrane domain and a large extracellular
           ectodomain that contains the active site. It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and is present in a variety
           of human tissues and cell types. APN expression is
           dysregulated in many inflammatory diseases and is
           enhanced in numerous tumor cells, making it a lead
           target in the development of anti-cancer and
           anti-inflammatory drugs. LTA4H is a bifunctional enzyme,
           possessing an aminopeptidase as well as an epoxide
           hydrolase activity. The two activities occupy different,
           but overlapping sites. The activity and physiological
           relevance of the aminopeptidase in LTA4H is as yet
           unknown while the epoxide hydrolase converts leukotriene
           A4 (LTA4) into leukotriene B4 (LTB4), a potent
           chemotaxin that is fundamental to the inflammatory
           response of mammals.
          Length = 407

 Score = 55.1 bits (133), Expect = 7e-10
 Identities = 23/53 (43%), Positives = 28/53 (52%), Gaps = 4/53 (7%)

Query: 71  IREKFLLTSKHQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFA 123
             +  LL        A  +   +V+ HE  HQWFG+LVT A WN  WLNE FA
Sbjct: 252 FSQSLLLAMI----DAGDELLENVIAHELAHQWFGNLVTGARWNDLWLNEGFA 300



 Score = 53.2 bits (128), Expect = 3e-09
 Identities = 21/38 (55%), Positives = 25/38 (65%)

Query: 14  ADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFA 51
           A  +   +V+ HE  HQWFG+LVT A WN  WLNE FA
Sbjct: 263 AGDELLENVIAHELAHQWFGNLVTGARWNDLWLNEGFA 300


>gnl|CDD|189006 cd09599, M1_LTA4H, Peptidase M1 family contains leukotriene A4
           hydrolase.  This family includes leukotriene A4
           hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog
           cold-active aminopeptidase (Colwellia
           psychrerythraea-type peptidase; ColAP), both members of
           the aminopeptidase M1 family. LTA4H, is a bifunctional
           enzyme possessing an aminopeptidase as well as an
           epoxide hydrolase activity.  The two activities occupy
           different, but overlapping sites. The activity and
           physiological relevance of the aminopeptidase is as yet
           unknown while the epoxide hydrolase converts leukotriene
           A4 (LTA4) into leukotriene B4 (LTB4), a potent
           chemotaxin that is fundamental to the inflammatory
           response of mammals. It accepts a variety of substrates,
           including some opioid, di- and tripeptides, as well as
           chromogenic aminoacyl-p-nitroanilide derivatives. The
           aminopeptidase activity of LTA4H is possibly involved in
           the processing of peptides related to inflammation and
           host defense. Kinetic analysis shows that LTA4H
           hydrolyzes arginyl tripeptides with high efficiency and
           specificity, indicating its function as an arginyl
           aminopeptidase. LTA4H is overexpressed in certain human
           cancers, and has been identified as a functionally
           important target for mediating anticancer properties of
           resveratrol, a well known red wine polyphenolic compound
           with cancer chemopreventive activity.
          Length = 442

 Score = 51.4 bits (124), Expect = 1e-08
 Identities = 18/36 (50%), Positives = 20/36 (55%)

Query: 20  TSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFE 55
             VV HE  H W G+LVT A+W   WLNE F    E
Sbjct: 283 VDVVAHEIAHSWSGNLVTNATWEHFWLNEGFTVYLE 318



 Score = 51.4 bits (124), Expect = 1e-08
 Identities = 18/36 (50%), Positives = 20/36 (55%)

Query: 92  TSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFE 127
             VV HE  H W G+LVT A+W   WLNE F    E
Sbjct: 283 VDVVAHEIAHSWSGNLVTNATWEHFWLNEGFTVYLE 318


>gnl|CDD|222169 pfam13485, Peptidase_MA_2, Peptidase MA superfamily. 
          Length = 128

 Score = 44.5 bits (105), Expect = 1e-06
 Identities = 12/42 (28%), Positives = 14/42 (33%)

Query: 15 DFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEY 56
          D      V+ HE  H   G+LV        WL E  A     
Sbjct: 21 DPDELRGVLAHELAHVVLGNLVGGNGNLPRWLTEGLAEYVAG 62



 Score = 44.5 bits (105), Expect = 1e-06
 Identities = 12/42 (28%), Positives = 14/42 (33%)

Query: 87  DFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEY 128
           D      V+ HE  H   G+LV        WL E  A     
Sbjct: 21  DPDELRGVLAHELAHVVLGNLVGGNGNLPRWLTEGLAEYVAG 62


>gnl|CDD|233856 TIGR02411, leuko_A4_hydro, leukotriene A-4
           hydrolase/aminopeptidase.  Members of this family
           represent a distinctive subset within the zinc
           metallopeptidase family M1 (pfam01433). The majority of
           the members of pfam01433 are aminopeptidases, but the
           sequences in this family for which the function is known
           are leukotriene A-4 hydrolase. A dual epoxide hydrolase
           and aminopeptidase activity at the same active site is
           indicated. The physiological substrate for
           aminopeptidase activity is not known.
          Length = 602

 Score = 43.6 bits (103), Expect = 7e-06
 Identities = 15/29 (51%), Positives = 18/29 (62%)

Query: 22  VVTHEFTHQWFGDLVTPASWNFAWLNEAF 50
           V+ HE  H W G+LVT  SW   WLNE +
Sbjct: 282 VIAHELAHSWSGNLVTNCSWEHFWLNEGW 310



 Score = 43.6 bits (103), Expect = 7e-06
 Identities = 15/29 (51%), Positives = 18/29 (62%)

Query: 94  VVTHEFTHQWFGDLVTPASWNFAWLNEAF 122
           V+ HE  H W G+LVT  SW   WLNE +
Sbjct: 282 VIAHELAHSWSGNLVTNCSWEHFWLNEGW 310


>gnl|CDD|189001 cd09594, GluZincin, Peptidase Gluzincin family (thermolysin-like
           proteinases, TLPs) includes peptidases M1, M2, M3, M4,
           M13, M32 and M36 (fungalysins).  Gluzincin family
           (thermolysin-like peptidases or TLPs) includes several
           zinc-dependent metallopeptidases such as the M1, M2, M3,
           M4, M13, M32, M36 peptidases (MEROPS classification),
           and contain HEXXH and EXXXD motifs as part of their
           active site. All peptidases in this family bind a single
           catalytic zinc ion which is tetrahedrally co-ordinated
           by three amino acid ligands and a water molecule that
           forms the nucleophile on activation during catalysis. M1
           family includes aminopeptidase N (APN) and leukotriene
           A4 hydrolase (LTA4H).  APN preferentially cleaves
           neutral amino acids from the N-terminus of oligopeptides
           and is present in a variety of human tissues and cell
           types. LTA4H is a bifunctional enzyme, possessing an
           aminopeptidase as well as an epoxide hydrolase activity
           such that the two activities occupy different, but
           overlapping sites. The peptidase M3 or neurolysin-like
           family, includes M3, M2 and M32 metallopeptidases.  The
           M3 peptidases have two subfamilies: M3A, includes thimet
           oligopeptidase (TOP; endopeptidase 3.4.24.15),
           neurolysin (3.4.24.16), and the mitochondrial
           intermediate peptidase; M3B contains oligopeptidase F.
           M2 peptidase angiotensin converting enzyme (ACE, EC
           3.4.15.1) catalyzes the conversion of decapeptide
           angiotensin I to the potent vasopressor octapeptide
           angiotensin II. ACE is a key part of the
           renin-angiotensin system that regulates blood pressure,
           thus ACE inhibitors are important for the treatment of
           hypertension. M32 family includes two eukaryotic enzymes
           from protozoa Trypanosoma cruzi, a causative agent of
           Chagas' disease, and Leishmania major, a parasite that
           causes leishmaniasis, making them attractive targets for
           drug development. The M4 family includes secreted
           protease  thermolysin (EC 3.4.24.27), pseudolysin,
           aureolysin, neutral protease as well as fungalysin and
           bacillolysin (EC 3.4.24.28) that degrade extracellular
           proteins and peptides for bacterial nutrition,
           especially prior to sporulation. Thermolysin is widely
           used as a nonspecific protease to obtain fragments for
           peptide sequencing as well as in production of the
           artificial sweetener aspartame. M13 family includes
           neprilysin (EC 3.4.24.11) and endothelin-converting
           enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad
           range of physiological roles due to the greater
           variation in the S2' subsite allowing substrate
           specificity and are prime therapeutic targets for
           selective inhibition. Peptidase M36 (fungamysin) family
           includes endopeptidases from pathogenic fungi.
           Fungalysin hydrolyzes extracellular matrix proteins such
           as elastin and keratin. Aspergillus fumigatus causes the
           pulmonary disease aspergillosis by invading the lungs of
           immuno-compromised animals and secreting fungalysin that
           possibly breaks down proteinaceous structural barriers.
          Length = 125

 Score = 38.2 bits (89), Expect = 2e-04
 Identities = 13/41 (31%), Positives = 15/41 (36%), Gaps = 5/41 (12%)

Query: 22  VVTHEFTHQWFGDLVT-----PASWNFAWLNEAFARLFEYF 57
           VV HE TH     LV        +     LNE  +  FE  
Sbjct: 72  VVGHELTHGVTDQLVGNDPDLLYTNGSGGLNEGPSDFFELL 112



 Score = 38.2 bits (89), Expect = 2e-04
 Identities = 13/41 (31%), Positives = 15/41 (36%), Gaps = 5/41 (12%)

Query: 94  VVTHEFTHQWFGDLVT-----PASWNFAWLNEAFARLFEYF 129
           VV HE TH     LV        +     LNE  +  FE  
Sbjct: 72  VVGHELTHGVTDQLVGNDPDLLYTNGSGGLNEGPSDFFELL 112


>gnl|CDD|233858 TIGR02414, pepN_proteo, aminopeptidase N, Escherichia coli type.
           The M1 family of zinc metallopeptidases contains a
           number of distinct, well-separated clades of proteins
           with aminopeptidase activity. Several are designated
           aminopeptidase N, EC 3.4.11.2, after the Escherichia
           coli enzyme, suggesting a similar activity profile (see
           SP|P04825 for a description of catalytic activity). This
           family consists of all aminopeptidases closely related
           to E. coli PepN and presumed to have similar (not
           identical) function. Nearly all are found in
           Proteobacteria, but members are found also in
           Cyanobacteria, plants, and apicomplexan parasites. This
           family differs greatly in sequence from the family of
           aminopeptidases typified by Streptomyces lividans PepN
           (TIGR02412), from the membrane bound aminopeptidase N
           family in animals, etc [Protein fate, Degradation of
           proteins, peptides, and glycopeptides].
          Length = 863

 Score = 39.2 bits (92), Expect = 2e-04
 Identities = 16/40 (40%), Positives = 23/40 (57%)

Query: 74  KFLLTSKHQCTTADFQRATSVVTHEFTHQWFGDLVTPASW 113
           K++L      T AD++R  SV+ HE+ H W G+ VT   W
Sbjct: 266 KYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDW 305



 Score = 38.8 bits (91), Expect = 3e-04
 Identities = 16/40 (40%), Positives = 23/40 (57%)

Query: 2   KFLLTSKGQCTTADFQRATSVVTHEFTHQWFGDLVTPASW 41
           K++L      T AD++R  SV+ HE+ H W G+ VT   W
Sbjct: 266 KYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDW 305


>gnl|CDD|189007 cd09600, M1_APN_1, Peptidase M1 family containing Aminopeptidase N.
            This family contains aminopeptidase N (APN; CD13;
           Alanyl aminopeptidase; EC 3.4.11.2), a Type II integral
           membrane protease belonging to the M1 gluzincin family.
           It includes bacterial-type alanyl aminopeptidases as
           well as PfA-M1 aminopeptidase (Plasmodium
           falciparum-type). APN consists of a small N-terminal
           cytoplasmic domain, a single transmembrane domain and a
           large extracellular ectodomain that contains the active
           site. It preferentially cleaves neutral amino acids from
           the N-terminus of oligopeptides and, in higher
           eukaryotes, is present in a variety of human tissues and
           cell types (leukocyte, fibroblast, endothelial and
           epithelial cells). APN expression is dysregulated in
           inflammatory diseases such as chronic pain, rheumatoid
           arthritis, multiple sclerosis, systemic sclerosis,
           systemic lupus erythematosus,
           polymyositis/dermatomyosytis and pulmonary sarcoidosis,
           and is enhanced in tumor cells such as melanoma, renal,
           prostate, pancreas, colon, gastric and thyroid cancers.
           It is predominantly expressed on stem cells and on cells
           of the granulocytic and monocytic lineages at distinct
           stages of differentiation, thus considered a marker of
           differentiation. Thus, APN inhibition may lead to the
           development of anti-cancer and anti-inflammatory drugs.
           APNs are also present in many pathogenic bacteria and
           represent potential drug targets, Some APNs have been
           used commercially, such as one from Lactococcus lactis
           used in the food industry. APN also serves as a receptor
           for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs have also been extensively studied
           as putative Cry toxin receptors. Cry1 proteins are
           pore-forming toxins that bind to the midgut epithelial
           cell membrane of susceptible insect larvae, causing
           extensive damage. Several different toxins, including
           Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have
           been shown to bind to APNs; however, a direct role of
           APN in cytotoxicity has been yet to be firmly
           established.
          Length = 861

 Score = 38.8 bits (91), Expect = 3e-04
 Identities = 16/40 (40%), Positives = 22/40 (55%)

Query: 74  KFLLTSKHQCTTADFQRATSVVTHEFTHQWFGDLVTPASW 113
           K +L      T AD++R  SV+ HE+ H W G+ VT   W
Sbjct: 266 KLVLADPETATDADYERIESVIGHEYFHNWTGNRVTCRDW 305



 Score = 38.4 bits (90), Expect = 5e-04
 Identities = 16/40 (40%), Positives = 22/40 (55%)

Query: 2   KFLLTSKGQCTTADFQRATSVVTHEFTHQWFGDLVTPASW 41
           K +L      T AD++R  SV+ HE+ H W G+ VT   W
Sbjct: 266 KLVLADPETATDADYERIESVIGHEYFHNWTGNRVTCRDW 305


>gnl|CDD|189011 cd09604, M1_APN_5, Peptidase M1 family containing bacterial
           Aminopeptidase N.  This family contains bacterial
           aminopeptidase N (APN; CD13; Alanyl aminopeptidase; EC
           3.4.11.2), a Type II integral membrane protease
           belonging to the M1 gluzincin family. APN consists of a
           small N-terminal cytoplasmic domain, a single
           transmembrane domain and a large extracellular
           ectodomain that contains the active site.  It
           preferentially cleaves neutral amino acids from the
           N-terminus of oligopeptides and, in higher eukaryotes,
           is present in a variety of human tissues and cell types
           (leukocyte, fibroblast, endothelial and epithelial
           cells). APN expression is dysregulated in inflammatory
           diseases such as chronic pain, rheumatoid arthritis,
           multiple sclerosis, systemic sclerosis, systemic lupus
           erythematosus, polymyositis/dermatomyosytis and
           pulmonary sarcoidosis, and is enhanced in tumor cells
           such as melanoma, renal, prostate, pancreas, colon,
           gastric and thyroid cancers. It is predominantly
           expressed on stem cells and on cells of the granulocytic
           and monocytic lineages at distinct stages of
           differentiation, thus considered a marker of
           differentiation. Thus, APN inhibition may lead to the
           development of anti-cancer and anti-inflammatory drugs.
           APNs are also present in many pathogenic bacteria and
           represent potential drug targets, Some APNs have been
           used commercially, such as one from Lactococcus lactis
           used in the food industry. APN also serves as a receptor
           for coronaviruses, although the virus receptor
           interaction site seems to be distinct from the enzymatic
           site and aminopeptidase activity is not necessary for
           viral infection. APNs have also been extensively studied
           as putative Cry toxin receptors. Cry1 proteins are
           pore-forming toxins that bind to the midgut epithelial
           cell membrane of susceptible insect larvae, causing
           extensive damage. Several different toxins, including
           Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have
           been shown to bind to APNs; however, a direct role of
           APN in cytotoxicity has been yet to be firmly
           established.
          Length = 435

 Score = 38.5 bits (90), Expect = 3e-04
 Identities = 16/62 (25%), Positives = 23/62 (37%), Gaps = 1/62 (1%)

Query: 15  DFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFGTRMLYVQEIPTPIREK 74
            F   T +  HE  HQW+  +V     N  WL+E        +     Y +E     R +
Sbjct: 285 PFILETVLA-HEIAHQWWYGIVGNDERNEPWLDEGLTTYLTDYYLEERYGKEAARLYRLR 343

Query: 75  FL 76
            L
Sbjct: 344 RL 345



 Score = 34.6 bits (80), Expect = 0.007
 Identities = 12/37 (32%), Positives = 16/37 (43%), Gaps = 1/37 (2%)

Query: 87  DFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFA 123
            F   T +  HE  HQW+  +V     N  WL+E   
Sbjct: 285 PFILETVLA-HEIAHQWWYGIVGNDERNEPWLDEGLT 320


>gnl|CDD|237585 PRK14015, pepN, aminopeptidase N; Provisional.
          Length = 875

 Score = 33.6 bits (78), Expect = 0.020
 Identities = 15/36 (41%), Positives = 22/36 (61%)

Query: 74  KFLLTSKHQCTTADFQRATSVVTHEFTHQWFGDLVT 109
           K++L      T AD++R  SV+ HE+ H W G+ VT
Sbjct: 279 KYVLADPETATDADYERIESVIAHEYFHNWTGNRVT 314



 Score = 31.6 bits (73), Expect = 0.091
 Identities = 15/36 (41%), Positives = 22/36 (61%)

Query: 2   KFLLTSKGQCTTADFQRATSVVTHEFTHQWFGDLVT 37
           K++L      T AD++R  SV+ HE+ H W G+ VT
Sbjct: 279 KYVLADPETATDADYERIESVIAHEYFHNWTGNRVT 314


>gnl|CDD|189018 cd09839, M1_TAF2, TATA binding protein (TBP) associated factor 2.
           This family includes TATA binding protein (TBP)
           associated factor 2 (TAF2, TBP-associated factor
           TAFII150, transcription initiation factor TFIID subunit
           2, RNA polymerase II TBP-associated factor subunit B),
           and has homology to the aminopeptidase N (APN)
           subfamily, belonging to the M1 gluzincin family. TAF2 is
           part of the TFIID multidomain subunit complex essential
           for transcription of most protein-encoded genes by RNA
           polymerase II. TAF2 is known to interact with the
           initiator element (Inr) found at the transcription start
           site of many genes, thus possibly playing a key role in
           promoter binding as well as start-site selection. Image
           analysis has shown TAF2 to form a complex with TAF1 and
           TBP, inferring its role in promoter recognition.
           Peptidases in the M1 family bind a single catalytic zinc
           ion which is tetrahedrally co-ordinated by three amino
           acid ligands and a water molecule that forms the
           nucleophile on activation during catalysis. TAF2,
           however, does not seem to contain any of the active site
           residues.
          Length = 507

 Score = 30.8 bits (70), Expect = 0.17
 Identities = 9/23 (39%), Positives = 14/23 (60%)

Query: 30  QWFGDLVTPASWNFAWLNEAFAR 52
           QWFG  ++P +W+  WL +  A 
Sbjct: 325 QWFGCFISPEAWSDEWLLKGIAG 347



 Score = 30.8 bits (70), Expect = 0.17
 Identities = 9/23 (39%), Positives = 14/23 (60%)

Query: 102 QWFGDLVTPASWNFAWLNEAFAR 124
           QWFG  ++P +W+  WL +  A 
Sbjct: 325 QWFGCFISPEAWSDEWLLKGIAG 347


>gnl|CDD|219383 pfam07348, Syd, Syd protein (SUKH-2).  This family contains a
           number of bacterial Syd proteins approximately 180
           residues long. It has been suggested that Syd is loosely
           associated with the cytoplasmic surface of the
           cytoplasmic membrane, and that interaction with SecY may
           be involved in this membrane association. Operon
           analysis showed that Syd protein may function as
           immunity protein in bacterial toxin systems.
          Length = 176

 Score = 27.9 bits (63), Expect = 1.4
 Identities = 10/40 (25%), Positives = 14/40 (35%), Gaps = 9/40 (22%)

Query: 23  VTHEFTHQWFGDLVTPASWNF-------AWLNEAFARLFE 55
           +   +   + GDL   A +          W  E F RL E
Sbjct: 74  IKAFYGSYFSGDL--TAFFPGGEIELLQVWNEEDFERLQE 111



 Score = 27.9 bits (63), Expect = 1.4
 Identities = 10/40 (25%), Positives = 14/40 (35%), Gaps = 9/40 (22%)

Query: 95  VTHEFTHQWFGDLVTPASWNF-------AWLNEAFARLFE 127
           +   +   + GDL   A +          W  E F RL E
Sbjct: 74  IKAFYGSYFSGDL--TAFFPGGEIELLQVWNEEDFERLQE 111


>gnl|CDD|219965 pfam08676, MutL_C, MutL C terminal dimerisation domain.  MutL and
           MutS are key components of the DNA repair machinery that
           corrects replication errors. MutS recognises mispaired
           or unpaired bases in a DNA duplex and in the presence of
           ATP, recruits MutL to form a DNA signaling complex for
           repair. The N terminal region of MutL contains the
           ATPase domain and the C terminal is involved in
           dimerisation.
          Length = 144

 Score = 27.2 bits (61), Expect = 1.9
 Identities = 12/32 (37%), Positives = 17/32 (53%), Gaps = 3/32 (9%)

Query: 48  EAFARL---FEYFGTRMLYVQEIPTPIREKFL 76
           E  ARL    E FG   L V+ +P  +R++ L
Sbjct: 73  ELLARLGFELEEFGPNSLIVRSVPALLRQQNL 104


>gnl|CDD|200107 TIGR01465, cobM_cbiF, precorrin-4 C11-methyltransferase.  This
           model represents precorrin-4 C11-methyltransferase, one
           of two methyltransferases commonly referred to as
           precorrin-3 methylase (the other is precorrin-3B
           C17-methyltransferase, EC 2.1.1.131). This enzyme
           participates in the pathway toward the biosynthesis of
           cobalamin and related products [Biosynthesis of
           cofactors, prosthetic groups, and carriers, Heme,
           porphyrin, and cobalamin].
          Length = 247

 Score = 27.3 bits (61), Expect = 2.4
 Identities = 18/56 (32%), Positives = 21/56 (37%), Gaps = 11/56 (19%)

Query: 67  IPTPIREKFLLTSKHQCTTADFQRAT---SVVTHEFTHQWFGDLVTP------ASW 113
            P P  EK    +KH  T A F  A     VV     H +  D  TP      A+W
Sbjct: 140 TPMPEGEKLADLAKHGATMAIFLSAHILDKVVKELIEHGYSED--TPVAVVYRATW 193


>gnl|CDD|220254 pfam09471, Peptidase_M64, IgA Peptidase M64.  This is a family of
           highly selective metallo-endopeptidases. The primary
           structure of the Clostridium ramosum IgA proteinase
           shows no significant overall similarity to any other
           known metallo-endopeptidase.
          Length = 255

 Score = 26.6 bits (59), Expect = 4.3
 Identities = 14/50 (28%), Positives = 19/50 (38%), Gaps = 18/50 (36%)

Query: 81  HQCTTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFG 130
           +   TAD   A+ +  HEF H            +FA L +      EYF 
Sbjct: 199 YGTVTADNSWASYIAVHEFGH------------SFAGLAD------EYFY 230



 Score = 25.4 bits (56), Expect = 9.6
 Identities = 16/55 (29%), Positives = 22/55 (40%), Gaps = 18/55 (32%)

Query: 12  TTADFQRATSVVTHEFTHQWFGDLVTPASWNFAWLNEAFARLFEYFGTRMLYVQE 66
            TAD   A+ +  HEF H            +FA L +      EYF    +Y+ E
Sbjct: 202 VTADNSWASYIAVHEFGH------------SFAGLAD------EYFYGGCVYLGE 238


>gnl|CDD|201064 pfam00182, Glyco_hydro_19, Chitinase class I. 
          Length = 232

 Score = 25.9 bits (57), Expect = 6.2
 Identities = 7/26 (26%), Positives = 13/26 (50%)

Query: 23 VTHEFTHQWFGDLVTPASWNFAWLNE 48
           +HE T  W+     P +W + ++ E
Sbjct: 60 TSHETTGGWYTAPDGPYAWGYCFVRE 85



 Score = 25.9 bits (57), Expect = 6.2
 Identities = 7/26 (26%), Positives = 13/26 (50%)

Query: 95  VTHEFTHQWFGDLVTPASWNFAWLNE 120
            +HE T  W+     P +W + ++ E
Sbjct: 60  TSHETTGGWYTAPDGPYAWGYCFVRE 85


>gnl|CDD|176108 cd08416, PBP2_MdcR, The C-terminal substrate-binding domian of
           LysR-type transcriptional regulator MdcR, which involved
           in the malonate catabolism contains the type 2
           periplasmic binding fold.  This family includes the
           C-terminal substrate binding domain of LysR-type
           transcriptional regulator (LTTR) MdcR that controls the
           expression of the malonate decarboxylase (mdc) genes.
           Like other members of the LTTRs, MdcR is a positive
           regulatory protein for its target promoter and composed
           of two functional domains joined by a linker helix
           involved in oligomerization: an N-terminal HTH
           (helix-turn-helix) domain, which is responsible for the
           DNA-binding specificity, and a C-terminal
           substrate-binding domain, which is structurally
           homologous to the type 2 periplasmic binding proteins
           (PBP2). The PBP2 are responsible for the uptake of a
           variety of substrates such as phosphate, sulfate,
           polysaccharides, lysine/arginine/ornithine, and
           histidine. The PBP2 bind their ligand in the cleft
           between these domains in a manner resembling a Venus
           flytrap. After binding their specific ligand with high
           affinity, they can interact with a cognate membrane
           transport complex comprised of two integral membrane
           domains and two cytoplasmically located ATPase domains.
           This interaction triggers the ligand translocation
           across the cytoplasmic membrane energized by ATP
           hydrolysis.  Besides transport proteins, the PBP2
           superfamily includes the substrate- binding domains from
           ionotropic glutamate receptors, LysR-like
           transcriptional regulators, and unorthodox sensor
           proteins involved in signal transduction.
          Length = 199

 Score = 25.4 bits (56), Expect = 9.9
 Identities = 8/19 (42%), Positives = 10/19 (52%)

Query: 1   EKFLLTSKGQCTTADFQRA 19
           EKF+  S+G  T   F  A
Sbjct: 100 EKFVTLSEGFATYRGFDEA 118


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.326    0.134    0.451 

Gapped
Lambda     K      H
   0.267   0.0623    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 6,794,942
Number of extensions: 570237
Number of successful extensions: 748
Number of sequences better than 10.0: 1
Number of HSP's gapped: 745
Number of HSP's successfully gapped: 56
Length of query: 132
Length of database: 10,937,602
Length adjustment: 86
Effective length of query: 46
Effective length of database: 7,123,158
Effective search space: 327665268
Effective search space used: 327665268
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 15 ( 7.1 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.7 bits)
S2: 53 (24.4 bits)